ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 224 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,063,800 | +208.5% | 195,000 | +254.5% | 0.06% | +158.3% |
| Q2 2023 | $1,317,250 | -10.8% | 55,000 | -38.9% | 0.02% | +20.0% |
| Q3 2022 | $1,476,000 | -69.7% | 90,000 | -74.0% | 0.02% | -70.1% |
| Q2 2022 | $4,878,000 | -37.9% | 346,166 | +6.8% | 0.07% | -28.7% |
| Q1 2022 | $7,850,000 | +2.0% | 324,100 | -1.7% | 0.09% | +9.3% |
| Q4 2021 | $7,697,000 | +2056.0% | 329,700 | +1433.5% | 0.09% | +2050.0% |
| Q3 2021 | $357,000 | -80.6% | 21,500 | -71.4% | 0.00% | -83.3% |
| Q2 2021 | $1,836,000 | -80.4% | 75,300 | -79.2% | 0.02% | -88.1% |
| Q1 2021 | $9,356,000 | -0.4% | 362,700 | +106.3% | 0.20% | -6.5% |
| Q4 2020 | $9,398,000 | +152.6% | 175,800 | +94.9% | 0.22% | +147.1% |
| Q3 2020 | $3,721,000 | -27.3% | 90,200 | -14.6% | 0.09% | -48.8% |
| Q2 2020 | $5,121,000 | +8.1% | 105,657 | -4.6% | 0.17% | +6.9% |
| Q4 2019 | $4,737,000 | +38.7% | 110,700 | +16.5% | 0.16% | -10.7% |
| Q3 2019 | $3,416,000 | -0.1% | 95,000 | -25.7% | 0.18% | +3.5% |
| Q2 2019 | $3,420,000 | +81.9% | 127,900 | +82.7% | 0.17% | +65.4% |
| Q1 2019 | $1,880,000 | +242.4% | 70,000 | +94.4% | 0.10% | +141.9% |
| Q2 2018 | $549,000 | – | 36,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
| SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
| HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
| Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
| GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
| EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
| Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
| Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |